Cygnal Technologies Corp. has been selected to provide a dedicated communications network connecting four Greater T...
November 11, 2005
Cygnal Technologies Corp. has been selected to provide a dedicated communications network connecting four Greater Toronto Area locations of Apotex Inc., the largest Canadian-owned pharmaceutical company.
The five-year contract includes the implementation and maintenance of Nortel equipment and Rogers fiber to create a SONET metro area network, providing Apotex with dedicated bandwidth to more tightly integrate its major sites in the GTA.
“Cygnal has built 80% of the community networks in Ontario servicing the ‘MUSH sector’ — municipalities, universities, schools and hospitals,” said Todd Rutherford, President, Cygnal Network Solutions. “We are now applying this expertise to enterprise customers like Apotex who can realize tremendous benefits from connecting multiple sites through a scalable metro area network.”
After a period of rapid expansion during which it has completed major expansions to several sites, Apotex has found that some of its facilities require additional bandwidth to take full advantage of modern technologies.
“A dedicated network will accommodate our growing need for real-time communications and information sharing among technical and research staff,” said William Shanks, Apotex Manager of Telecommunications and Network Services.
Cygnal will implement a metro area network built on Nortel’s Optera Metro 3500 platform, utilizing a combination of Apotex’s existing fiber infrastructure and Rogers Cable’s fiber network to provide connectivity between the four sites. It will be configured as an OC-48 (2.488 gigabit per second) SONET network, scalable to OC-192 (10 Gbps).
Redundancy features will automatically reroute traffic in the event network degradation or failure
are sensed. Cygnal’s ongoing support program will include network monitoring, remote and on-site diagnostics, repair and resolution.